ARCT:NASDAQ
Arcturus Therapeutics Holdings Inc
၇.၄၅ US$
arrow_downward
-၁.၉၇%(-၀.၁၅) 1D
၇.၅၅ US$
arrow_upward
+၁.၃၄% (+၀.၁၀)bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARCT...
Open
၇.၄၀ US$
High
၇.၇၃ US$
Low
၇.၃၁ US$
Mkt. cap
၂၁.၄၇ ကုဋေ
Avg. vol.
၆.၅၂ သိန်း
Volume
၆.၀၂ သိန်း
52-wk high
၁၇.၉၆ US$
52-wk low
၅.၅၀ US$
EPS
-၃.၀၈ US$
Beta
၂.၆၂
Shares outstanding
၂.၈၈ ကုဋေ
No. of employees
၁၀၉
Open
၇.၄၀ US$
High
၇.၇၃ US$
Low
၇.၃၁ US$
Mkt. cap
၂၁.၄၇ ကုဋေ
Avg. vol.
၆.၅၂ သိန်း
Volume
၆.၀၂ သိန်း
52-wk high
၁၇.၉၆ US$
52-wk low
၅.၅၀ US$
EPS
-၃.၀၈ US$
Beta
၂.၆၂
Shares outstanding
၂.၈၈ ကုဋေ
No. of employees
၁၀၉
News stories
From web sources and news partners
24/7 Wall St.
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
His Indexed Annuity Tracks the S&P 500. The Fine Print Says "Price Return," Which Means It Leaves Out Every Dividend the 500 Companies Pay
Nacionale
·
ပြီးခဲ့သည့် ၁ နာရီ
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Benzinga
·
ပြီးခဲ့သည့် ၃၀ မိနစ်
S&P 500 Has Slumped Into a Correction as Goldman Sachs Panic Index Points to More Downside
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
Profile
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA.
The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025. Wikipedia
About Arcturus Therapeutics Holdings Inc
CEOJoseph E. Payne
Employees၁၀၉
Founded၂၀၁၃
Headquarters-
SectorHealth Care
Industry-
Websitearcturusrx.com